Survey of the application status of FIGO clinical staging system in cervical cancer in China between 2004 and 2016

Wei-feng ZHANG,Peng-fei LI,Chun-lin CHEN,Ping LIU,Ying YANG,Min HAO,Wei-dong ZHAO,Anwei LU,Qian-yong ZHU,En-cheng DAI,Yan NI,Long CHEN,Jing-he LANG

DOI: https://doi.org/10.19538/j.fk2018010116

2018-01-01

Abstract:Objective To investigate the application status of FIGO clinical staging system in cervical cancer in China.Methods A total of 31 599 cases of cervical cancer during the period from January 2004 to December 2016 were retrospectively reviewed.The original clinical stages were recorded and entered into a database.The standardized degree of clinical stage was evaluated by referring to the corresponding FIGO clinical staging system.Results Among the 31 599 cases,16 044(50.8％)were from general hospitals,13 822 (43.7％) from special tumor hospitals and 1733 (5.5％)from special women and children's hospitals.Non-standard application of FIGO clinical staging system were found in 6020 cases.Incomplete clinical staging (3265,54.24％) and no clinical staging(2395,39.78％)were the two most common forms of non-standard application,followed by discordance with gynecologic examination (182,3.02％);ambiguous staging such as Ⅰ B2-Ⅱ A 1,et al (102,1.69％) and stage revision postoperatively (76,1.26％).Based on analyses of associated factors,we found that age＞ 60 was associated positively with non-standard application of FIGO clinical staging(20.75％ vs.18.52％ vs.19.39％,P＜O.001);Exogenous growth pattern and maternal health care hospital were associated negatively with non-standard application of FIGO clinical staging (3.75％ vs.14.53％ vs.24.58％,P＜0.001).Conclusion Non-standard application of FIGO clinical stage was not uncommon and it occurrs more frequently in difficult situations such as old patients or non-exogenous growth patterns.